Bax-α promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells

Cell Death and Differentiation

Volumn 5, Issue 6, 1998, Pages 506-516

  Schmitt, Estelle ^a   Steyaert, Alain ^a   Cimoli, Guido ^a   Bertrand, Richard ^a,b  

^a Institut du Cancer de Montreal   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Bax; Cancer chemotherapy; Caspase; Lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; CYSTEINE PROTEINASE; DNA; DNA FRAGMENT; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; HYGROMYCIN; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN BAX; PROTEIN P53; VINBLASTINE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA CLEAVAGE; DNA SYNTHESIS INHIBITION; DNA TRANSFECTION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME KINETICS; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031870835     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400376     Document Type: Article

References (104)

1. Alnemri ES, Fernandes-Alnemn Tand Litwack G (1995) Cloning and expression of four novel isoforms of human tnterleukin-1 beta converting enzyme with different apoptotic activities. Journal of Biological Chemistry 270:4313-4317
2. Apte SS, Mattei MG and Olsen BR (1995) Mapping of the Human Bax gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, Baxδ. Genomics 26. 529-594
3. Bargou RC, Daniel PT, Mapara MY, Bommert K, WagenerC, Kallinich B, Royer HD and Dorken B (1995) Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. International Journal of Cancer 60 854-859
4. Barry MA, Behnke CA and Eastman A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hypothermia. Biochem Pharmacol. 40: 2353-2362
5. Bertrand R, Kohn K, Solary E and Pommier Y (1995) Detection of apoptosis-assoctated DNA fragmentation using a rapid and quantitative filter elution assay. Drug Development Res. 34: 138-144
6. Bertrand R, O'Connor P, Kerrigan Dand Pommier Y (1992) Sequential administration of camptothecin and etoposide circumvents the antagnostic cytotoxicity of simultaneous drug administration in slowly growing human carcinoma. HT-29 cells. Eur J Cancer 28A: 743-748
7. Bertrand R and Pommier Y (1995) Assessment of DNA damage in Mammalian cells by DNA filter elution methodology. In GP Studzinski (Ed.), Cell growth and apoptosis; A practical approach, (Vol. 159, pp. 97-118). New York. IRL Press
8. Bertrand R, Sarang M, Jenkin J, Kerrigan D and Pommier Y (1991) Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Research 51: 6280-6285
9. Bertrand R, Solary E, Jenkins J and Pommier Y (1993) Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Experimental Cell Research 207:388-397
10. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB (1993) bci-x, a bci-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
11. Boldin MP, Goncharov TM, Goltsev YV and Wallach D (1996) Involvement of mach, a novel mort1/fadd-interacting protease, in fas/Apo-1- and Tnf receptor-induced cell death Cell 85 803-815
12. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ. Ebb RG, Subramanian T, Chittenden T, Lutz RJ and Chinnadurai G (1995) Bik, a novel death-inducing protein sharesa distinct sequence motif with Bcl-2family proteins and interacts with viral and cellular survival-promoting proteins Oncogene 11 1921-1928
13. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC (1995) Induction of apoptosis by the Bcl-2 hormologue Bak. Nature 374: 733-736
14. Choi SS, Park IC, Yun JW, Sung YC, Hong SI and Shin HS (1995) A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698
15. Chresta CM, Masters JRW and Hickman JA (1996) Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax-Bcl-2 ratio Cancer Research 56. 1834-1841
16. Clarke ML, Smith SD and Sklar J (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14,18) translocation. Cell 47: 19-28
17. Das R, Reddy EP, Chatlerjee D and Andrews DW (1996) Identification of anovel Bcl-2 related gene, Brag-1, in human glioma. Oncogene 12:947-951
18. Datta R, Manome Y, Taneja N, Boise L, Weichselbaum R, Thompson C and Kufe D (1995) Overexpression of Bcl-xL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth and Differentiation 6. 363-370
19. Del Bino G, Bruno S, Yi PN and Darzynkiewicz Z (1992) Apoptotic cell death triggered by camptothecin or teniposide The cell cycle specificity and effects of ionizing radiation Cell Proliferation 25: 537-548
20. Deveraux QL, Takahashi R, Salvesen GS and Reed JC (1997) X-linked iap is a direct inhibitor of cell-death proteases. Nature 388. 300-304
21. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G and Castle VP (1995) Bcl-X(L) is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis Cancer Research 55: 2576-2582
22. Duan HJ, Chinnaiyan AM, Hudson PL, Wing JP, He WW and DiXit V (1996a) Ice-Lap3. a novel mammalian homologue of the caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. Journal of Biological Chemistry 271: 1621-1625
23. Duan HJ, Orth K, Chinnaiyan AM, Poiner GG, Froelich CJ, He WW and Dixit V (1996b) Ice-Lap3, a novel member of the Ice/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. Journal of Biological Chemtstry 271: 16720-16724
24. Ealovega MW, McGinnis PK, Sumantran VN, Clarke MF and Wicha MS (1996) Bcl-X(S) gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Research 56: 1965-1969
25. Fang W, Rivard JJ, Ganser JA, Lebien TW, Nath KA, Mueller DL and Behrens TW (1995) Bcl-X(L) rescues Wehi 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. Journal of Immunology 155. 66-75
26. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC and Brown R (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K Nature 374:731-733
27. Faucheu C, Blanchet AM, Collarddutilleul V, Lalanne JL and Diuhercend A (1996) Identification of a cysteine protease closely related to interleukirt-1-beta-converting enzyme European Journal of Biochemistry 236. 207-213
28. Faucheu C, DIU A, Chan AW, Blanchet AM, Miossec C, Herve F, Collard-Dutilleul V, Gu Y, Aldape RA, Lippke JA et al (1995) A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO Journal 14: 1914-1922
29. Femandes-Alnemri T, Amstrong RC, Krebs J, Snnivasula SM, Wang L, Bullrich F, Fntz LC, Trapani JA, Tomaselli KJ, Litwack G and Alnemri ES (1996) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FDD-like domains. Proc. Natl. Acad. Sci. USA 93: 7464-7469
30. Femandes-Alnemri T, Litwack G and Alnemri ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. Journal of Biological Chemistry 269:30761-30764
31. Femandes-Alnemri T, Lrtwack G and Alnemri E (1995) Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Research 55:2737-2742
32. Femandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G and Alnemri ES (1995) Mch3, a novel human apoptotic cysteine protease highly related to Cpp32. Cancer Research 5:6045-6052
33. Gibson L, Holmgreen SP, Huang DCS, Bernand O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM and Cory S (1996) Bcl-W, a novel member of the Bcl-2 family, promotes cell survival. Oncogene 13: 665-675
34. Gupta M, Fujimon A and Pommier Y (1995) Eukaryotic DNA topoisomerase I. Biochim. Biophysi. Acta 1262: 1-14
35. Hickman JA (1996) Apoptosis and chemotherapy resistance. European Journal of Cancer 32A: 921-926
36. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M and Kroemer G (1997) The apoptosis-necrosis paradox - apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15: 1573-1581
37. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
38. Hockenbery DM (1995) BCL-2, a novel regulator of cell death. Bioessays 17:631-638
39. Homer D, Lewis M and Farrell PJ (1995) Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers. Intervirology 38. 195-205
40. Ibrado AM, Huang Y, Fang GF and Bhalla K (1996) Bcl-X(L) overexpression inhibits taxol-induced yama protease activity and apoptosis. Cell Growth and Differentiation 7: 1087-1094
41. Jaxel C, Taudou G, Portemer C, Mirarnbeau G, Panijel J and Duguet M (1988) Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes. Biochemistry 27:95-99
42. Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P, Mankovich JA, Terranova M and Ghayur T (1995) Identification and characterization of Ich-2, a novel member of the interleukin-1-beta-converting enzyme family of cysteine proteases. Journal of Biological Chemistry 270: 15250-15256
43. Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs. a cautionary note. Cancer Research 49: 5870-5878
44. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR,Tomei LD and Barr PJ (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739
45. Kitanaka C, Namiki T, Noguchi K, Mochizuki T, Kagaya S, Chi S, Hayashi A, Asai A, Tsujimoto Y and Kuchino Y (1997) Caspase-dependent apoptosis of Cos-7 cells induced by Baxoverexpression-differential effects of Bcl-2and Bcl-X(L)On Bax-induced caspase activation and apoptosis Oncogene 15: 1763-1772
46. Klein G and Dombos L (1973) Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome. Int. J. Cancer 11:327
47. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ and Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270. 96-99
48. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80: 879-886
49. Korsmeyer SJ (1995) Regulators of cell death. [Review]. Trends in Genetics 11: 101-105
50. Kozopas KM, Yang T, Buchan HL, Zhou P and Craig RW (1995) MCL1. a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc. Natl. Acad. Sci. USA 90: 3516-3520
51. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S and Reed JC (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Research 55: 4471-4478
52. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG and Reed JC (1994) Immunohistochemical determination of In Vivo distribution of Bax, a dominant inhibitor of Bcl2. American Journal of Pathology 145: 1323-1336
53. Kumar S and Lavin MF (1996) The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ. 3: 255-267
54. Lawrence JB, Villnave CA and Singer RH (1988) Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma cell line. Cell 52: 51-61
55. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC (1994) Cleavage of poly(ADP-nbose) polymerase by a protemase with properties like ICE Nature 371: 346-347
56. Lin EY, Orlofsky A, Berger MS and Prystowsky MB (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2 J. Immunol. 151: 1979-1988
57. Lippke JA, Gu Y, Sarnecte C, Caron PR and Su MSS (1996) Identification and characterization of Cpp32/2mch2 homolog 1, a novel cysteine protease similar to Cpp32 Journal of Biological Chemistry 271: 1825-1828
58. Luka J, Lindahl T and Klein G (1978) Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines. Journal of Virology 27: 604-611
59. Matsuo T, Heller M, Petti L. O'Shiro E and Kieff E (1984) Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 226: 1322-1325
60. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC and Keating M (1996) Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. Journal of Immunology 156: 2624-2630
61. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215
62. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman Band Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
63. Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
64. Monney L, Otter I, Olivier R, Ravn U, Mirzasaleh H, Fellay I, Poirier GG and Borner C (1996) Bcl-2 overexpression blocks activation of the death protease Cpp32/ Yama/Apopain. Biochemical & Biophysical Research Communications 221: 340-345
65. Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK, Molineaux SM, Yamin TT, Yu VL and Nicholson DW (1995) Molecular cloning and pro-apoptotic activity of ICErelll and ICErellll, members of the ICE/CED-3 family of cystein proteases. Journal of Biological Chemistry 270: 15870-15876
66. Muzio M, Chinnaiyan AM, Kischkel FC, Orourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) Flice, a novel Fadd-homologous Ice/Ced-3-like protease, is recruited to the Cd95 (Fas/Apo-1) death-inducing signaling complex. Cell 85: 817-827
67. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
68. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW (1993) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Buricitt's lymphoma cell lines. Cancer Research 53: 4776-4780
69. Oltvai ZN and Korsmeyer SJ (1994) Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192
70. Oltvai ZN, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimenzes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
71. Patel T. Gores GJ and Kaufmann SH (1996) The role of proteases during apoptosis. FASEB Journal 10 587-597
72. Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, Braun D and Kieff E (1987) Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160: 151-161
73. Pommier Y (1997) DNA topoisomerase II inhibitors. In BA Teicher (Ed.), Cancer Therapeutics: Experimental and Clinical Agents, (pp. 153-174). Totowa, New Jersey Humana Press Inc
74. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y and Jacobson MD (1994) Programmed cell death and the control of cell survival. Philosophical Transactions of the Royal Society of London - Senes B. Biological Sciences 345: 265-268
75. Reed JC (1995) Bcl-2 family proteins - regulators of chemoresistance in cancer Toxicology Letters 3: 155-158
76. Reed JC (1997) Double identity for proteins of the Bcl-2 farmly. Nature 387:773-776
77. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomri S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K and Takahashi T (1996) Overexpression of Bax sensitizes human breast cancer Mcf-7 cells to radiation-induced apoptosis International Journal of Cancer 67: 101-105
78. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomon S, Tsujimoto H, Imanishi T. Ogaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K and Takahashi T (1997) Overexpression of Bax sensitizes breast cancer Mcf-7 cells to cisplatin and etoposide. Surgery Today 27: 676-679
79. Sample J, Liebowitz D and Kieff E (1989) Two related Epstein-Barr virus membrane proteins are encoded by separate genes. Journal of Virology 63: 933-937
80. Sane AT, Schmitt E, Steyaert A, Meyer D and Bertrand R (1997) The CrmA- and TPCK-sensitive pathways that trigger the oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and hig molecular weight DNA fragmentation. Biochemical and Cellular Biology 75: 359-368
81. Sawada K, Yamamoto M, Tabata T, Smith M, Tanaka A and Nonoyama M (1989) Expression of EBNA-3 family in fresh B lymphocytes infected with Epstein-Barr virus. Virology 168: 22-30
82. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB and Korsmeyer SJ (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl Acad Sci USA 92: 7834-7838
83. Shimizu S, Eguchi Y, Kamiike W, Matsuda H and Tsujimoto Y (1996) Bcl-2 expression prevents activation of the ice protease cascade Oncogene 12 2251-2257
84. Simonian PL, Grillot DAM, Menno R and Nunez G (1996) Bax can antagonize Bcl-X(L) during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-X(L) Journal of Biological Chemistry 271:22764-22772
85. Solary E, Bertrand R, Kohn KW and Pommier Y (1993) Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81: 1359-1368
86. Strobel T, Swanson L, Korsmeyer S and Cannistra SA (1996) Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc. Natl. Acad. Sci. USA 93 14094-14099
87. Sumantran VN, Ealovega MW, Nunez G, Clarke MF and Wicha MS (1995) Overexpression of Bcl-X(S), sensitizes Mcf-7 cells to chemotherapy-induced apoptosis Cancer Research 55: 2507-2510
88. Takayama S, Kochel K, Irie S, Inazawa J, Abe J, Sato T, Druck T, Huebner K and Reed JC (1996) Cloning of Cdnas encoding the human Bag 1 protein and localization of the human Bag1 gene to chromosome 9p12. Genomics 35: 494-498
89. Takayama S, SatoT, Krajewski S, Kochel K, Irie S, Millan JA and JC R (1995) Cloning and functional analysis of Bag-1; a novel Bcl-2 binding protein with anti-cell death activity. Cell 80: 279-284
90. Tewari M, Quan LT, Orourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM (1995) Yama/Cpp32-Beta, a mammalian homolog of Ced-3, is a Crma-inhibitable protease that cleaves the death substrate Poly(ADP-ribose) polymerase. Cell 81:801-809
91. Thomas A, Elrouby S, Reed JC, Krajewski S, Silber R, Potmesil M and Newcomb EW (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia - relationship between p53 gene mutation and Bcl-2/Bax proteins in drug resistance. Oncogene 12: 1055-1062
92. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462
93. Tsujiimoto Y, Finger LR, Yunis J, Nowell PC and Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 226: 1097-1099
94. Vaux DL, Cory S and Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 355.440-442
95. Wagener C, Bargou RC, Daniel PT, Bommert K, Mapara MY, Royer HD and Dorken B (1996) Induction of the death-promoting gene Bax-alpha sensitizes cultured breast cancer cells to drug-induced apoptosis. International Journal of Cancer 67: 138-141
96. Walker PR, Smith C, Youdale T, Leblanc J, Whitfield JF and Sikorska M (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes Cancer Research 51: 1078-1085
97. Wang L, Miura M, Bergeron L, Zhu H and Yuan J (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739-750
98. Wang K, Yin XM, Chao DT, Milliman CL and Korsmeyer SJ (1996) Bid-a novel Bh3 domain-only agonist Genes & Development 10: 2859-2869
99. Wang SY, Miura M, Jung YK, Zhu H, Gagliardini V, Shi LF, Greenberg AH and Yuan JY (1996) Identification and characterization of Ich-3, a member of the interleukin-1-beta converting enzyme (Ice)/Ced-3 family and an upstream regulator of Ice. Journal of Biological Chemistry 271: 20580-20587
100. Wyllie AH (1997) Apoptosis and carcinogenesis. European Journal of Cell Biology 73: 189-197
101. Xerri L, Parc P, Brousset P, Schlaifer D, Hassoun J, Reed JC, Krajewski S and Birnbaum D (1996) Predominant expression of the long isoform of Bcl-X (Bcl-XI) in human lymphomas. British Journal of Haematology 92: 900-906
102. Xiang JL, Chao DT and Korsmeyer SJ (1996) Bax-induced cell death may not require interleukin 1-beta-converting enzyme-like proteases. Proc. Natl.Acad Sci. USA 93: 14559-14563
103. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ (1995) Bad. a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291
104. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz R (1993) The C. elegans cell death gene ced-3 encodes a protein similarto mammalian interleukine-1B-converting enzyme. Cell 75: 641-652